Dang Thi Hai Van

Dang Thi Hai Van

Auto-generated profile, based on publicly available information

Dang Thi Hai Van

Ha Noi Medical University, Hanoi, Vietnam

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2024 in Vietnam Journal of Biotechnology
Verified
Journal Article
Open access
PDF file
NLNguyen Thi Kim Lien
Nguyen Thi Kim Lien
TNTung Van Nguyen
Tung Van Nguyen
LTLÊ TRỌNG TÚ
LÊ TRỌNG TÚ
DVDang Thi Hai Van
Dang Thi Hai Van
VNVu Quynh Nga
Vu Quynh Nga
NHNguyen Hoang
Nguyen Hoang
Hypertrophic cardiomyopathy (HCM) is a common genetic cardiovascular disease and a major cause of sudden death. It is also involved with increased morbidity and mortality of various cardiovascular diseases. Genetic factors have been identified as playing an important role in determining the phenotypic manifestation of cardiac hypertrophy. However, only 50–60% of HCM patients have been identified as having mutations in known genes, suggesting that studies are needed to find more disease genes. HCM is an autosomal dominant disorder caused by mutations in genes encoding for sarcomeric proteins and proteins involved in many cardiomyocyte signaling pathways that activate protein tyrosine kinases. The role of specific protein tyrosine phosphatases (PTPs) in these pathways is unknown. Advances in next-generation sequencing (NGS) technology allow the application of genetic analysis-based diagnostics to become more widespread and help differentiate HCM from other cardiomyopathies. The results of genetic diagnosis will provide insights into the cell biology and pathogenesis of HCM as a basis for developing therapies that can prevent or treat patients. In this study, whole exome sequencing was performed on two patients who were diagnosed with HCM to screen the associated mutations. Two heterozygous mutations c.836A>C, p.Tyr279Ser and c.83A>C, p.His28Pro have been identified in the PTPN11 and PRKAG2 gene, respectively. These results have provided an understanding of the cause of the patient’s disease, helping clinicians diagnose and provide genetic counseling to the patient's family.

1 January 2024 in Global Pediatric Health
Verified
Journal Article
Open access
NANguyen Thi Hai Anh
Nguyen Thi Hai Anh
DTDien Minh Tran
Dien Minh Tran
LHLe Thi Ha
Le Thi Ha
PNPham Thao Nguyen
Pham Thao Nguyen
DVDang Thi Hai Van
Dang Thi Hai Van
Objectives. To identify factors associated with pulmonary hypertension (PH) at 28 days of life in preterm infants with bronchopulmonary dysplasia (BPD). Methods. This observational study included 128 premature infants with BPD between January 2022 and February 2023 from the neonatal intensive care unit of Vietnam National Children’s Hospital. Results. PH was observed using echocardiography in 29 patients (22.66%). The prevalence of severe BPD in the PH group (62.07%) was significantly higher than that in the non-PH group (18.18%). The multivariate logistic regression showed 2 predictors of PH in BPD: invasive mechanical ventilation up to 28 days of life (odds ratio [OR]:9.440; 95% confidence interval [CI]: 3.090-28.833; P < .001) and history of shock (OR: 2.962; 95% CI: 1.067-8.225; P = .037). Conclusion. We found 2 predictors of PH at 28 days of life in BPD: invasive mechanical ventilation up to 28 days of life and history of shock.

29 November 2019
Verified
Book Chapter
Closed access
PDF file
HPHUY GIAO PHAM
HUY GIAO PHAM
NANguyen Thi Hai Anh
Nguyen Thi Hai Anh
HKHoang Ngoc Khai
Hoang Ngoc Khai

17 October 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
LTLÊ TRỌNG TÚ
LÊ TRỌNG TÚ
NLNguyen Thi Kim Lien
Nguyen Thi Kim Lien
TNTung Van Nguyen
Tung Van Nguyen
DVDang Thi Hai Van
Dang Thi Hai Van
VNVu Quynh Nga
Vu Quynh Nga
NHNguyen Hoang
Nguyen Hoang
Background: Functional single ventricle (FSV) comprises a heterogeneous group of congenital heart diseases (CHDs) with severe and complex abnormalities. The multifactorial etiology of the disease poses challenges in identifying specific pathogenic factors and planning effective interventions and preventive treatments for patients. Methods: Whole-exome sequencing (WES) was performed to identify variants in relevant genes in 29 FSV patients from different families. Results: In total, 95 heterozygous variants across 48 CHD-associated genes were identified, including 85 missense, four small indel, one splicing, one stop gain, and four synonymous variants. Among them, 22 were novels, 11 conflicting, and four pathogenic variants. Each patient carried from two to six variants in different genes, including at least one variant in genes associated with serious heart defects such as AXIN1, BMP2, COL6A2, GATA4, GATA5, GDF1, MESP1, MYH6, NFATC1, NKX2-6, NOTCH1, PCSK9, TBX1, TBX18, and TBX20. In addition, the variants in the COL6A1, CREBBP, DOCK6, EOGT, EP300, LRP2, MYBPC3, MYH7, SEMA3C, and ZFPM2 genes are associated with characteristic phenotypes of FSV, such as atrial septal defect, ventricular septal defect, small left heart syndrome, transposition of the great arteries, and double outlet right ventricle occurring at high frequency in patients. The prediction results suggest that these are potentially pathogenic variants in patients and may explain the phenotype in patients. Conclusions: This is the first study to identify variants associated with functional single ventricle, a complex form of congenital heart disease. Our results contribute to a general understanding of the causes of the disease, thereby guiding treatment and prevention approaches for patients.